Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Active not recruiting × Midazolam × Clear all

Phase

Phase 2 2 Phase 3 1 Phase 1/2 1 Phase 1 1

Status

Completed 1 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 1

Interventions

Carboplatin 92 Cisplatin 84 Paclitaxel 72 pembrolizumab 59 Cyclophosphamide 47 Gemcitabine 46 Capecitabine 42 durvalumab 41 Pemetrexed 40 Dexamethasone 40 Doxorubicin 38 Docetaxel 37 Radiotherapy 36 Nivolumab 33 Lenalidomide 33 Bevacizumab 32 Specimen Handling 30 Rituximab 30 Oxaliplatin 30 Vincristine 28 Magnetic Resonance Spectroscopy 28 Fluorouracil 28 Etoposide 28 atezolizumab 26 Radiation 24 Prednisone 24 Leucovorin 24 Bortezomib 24 130-nm albumin-bound paclitaxel 21 Letrozole 18

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05646862 2026-02-05

INAVO121

Hoffmann-La Roche

Phase 3 Active not recruiting

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡